tirzepatide drug shortage list Resolved: What It Means for Your Weight Loss Journey Lilly's weight-loss drug removed from

The pharmacy prepares your medication, packages it, and ships it directly to your address

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the annual meeting of the American Academy of Orthopaedic Surgeons

The combination of positive outcomes and support may assist individuals in maintaining their treatment and healing both mind and body

Weight Loss Results: In a 48-week trial with people who had obesity: 12 mg dose: Average weight loss of 24.2% 8 mg dose: Average weight loss of 17.5% Placebo: Weight loss of 2.1% Let me put that in perspective: If you weigh 250 pounds: 24.2% weight loss = 60 pounds lost And people were still losing weight when the trial ended (no plateau reached yet) How this compares to other medications: Semaglutide (Wegovy): ~15% weight loss Tirzepatide (Zepbound): ~20% weight loss Retatrutide: ~24% weight loss This is the most significant weight loss we've seen with any medication to date